A.H. van der Veen

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

A.H. van der Veen, Jan Dees, Jan D. Blankensteijn et al. · Gut · 1989 · 219 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

TNF- α augments intratumoural concentrations of doxorubicin in TNF- α -based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

A.H. van der Veen, Johannes H. W. de Wilt, A.M.M. Eggermont et al. · British Journal of Cancer · 2000 · 150 citations · Full text

Medicine, Oncology, Pharmacology +12

Evaluation of Quality of Life After Nonoperative or Operative Management of Proximal Femoral Fractures in Frail Institutionalized Patients

Sverre A. I. Loggers, Hanna C. Willems, Romke van Balen et al. · JAMA Surgery · 2022 · 106 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats

Timo L.M. ten Hagen, A.H. van der Veen, Peet Nooijen et al. · International Journal of Cancer · 2000 · 81 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of Antibiotic Prophylaxis on Surgical Site Infections Following Removal of Orthopedic Implants Used for Treatment of Foot, Ankle, and Lower Leg Fractures

Manouk Backes, Siem A. Dingemans, Marcel G. W. Dijkgraaf et al. · JAMA · 2017 · 54 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17